Related Experiment Video
Updated: Jul 19, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways
1Department of Dermatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.
Background:
Aberrant methylation of CpG islands in the promoter regions of cancer-related genes has been demonstrated in many human tumours. However, the methylation profile of these regions in cutaneous squamous cell carcinomas (SCCs) has not been well studied.
Objectives:
To examine epigenetic abnormalities of a wide range of cancer-related genes in SCCs.
Methods:
We investigated the methylation status of 11 candidate cancer-related genes (CDH1, p16(INK4a), p14(ARF), DAPK1, MGMT, RB1, RASSF1, p15(INK4b), PTEN, PRDM2 and p53) in 20 cases of SCC by methylation-specific polymerase chain reaction, and comparatively examined the protein production of E-cadherin (CDH1), p16, RB1, p14, BMI1 and cyclin A by immunohistochemical analysis.
Results:
The frequency of cancer-related gene methylation in SCCs was: CDH1 (95%), p16 (20%), p14 (15%), DAPK1 (15%), MGMT (15%), RB1 (5%), RASSF1 (5%), p15 (0%), PTEN (0%), PRDM2 (0%) and p53 (0%). Almost all cases with hypermethylation of CDH1, p16, RB1 and p14 showed no obvious production of each protein, suggesting that promoter hypermethylation of these genes contributes to the loss of protein production. The results of methylation analysis, in combination with the results of our previous mutation analysis of CDKN2A locus and p53, revealed that 70% of SCCs have alterations in the RB1/p16 or p53 pathway.
Conclusions:
Our findings indicate that the promoter hypermethylation of cancer-related genes, especially CDH1, is frequently shown in SCCs, and dysregulation of the RB1/p16 and/or p53 pathway through either genetic or epigenetic mechanisms, except for epigenetic abnormalities of p53 itself, should contribute to the carcinogenesis of SCCs.
Insights
Aberrant promoter hypermethylation of cancer-related genes, particularly CDH1, is common in cutaneous squamous cell carcinomas (SCCs). These epigenetic changes, along with RB1/p16 or p53 pathway dysregulation, contribute to SCC development.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant methylation of CpG islands in promoter regions of cancer-related genes is observed in various human tumors.
- The methylation profile in cutaneous squamous cell carcinomas (SCCs) remains understudied.
Purpose of the Study:
- To investigate epigenetic abnormalities in a broad spectrum of cancer-related genes within SCCs.
- To correlate gene methylation status with protein production.
Main Methods:
- Methylation-specific polymerase chain reaction (PCR) was used to analyze the methylation status of 11 candidate cancer-related genes in 20 SCC cases.
- Immunohistochemical analysis assessed the protein production of key genes including E-cadherin (CDH1), p16, RB1, and p14.
Main Results:
- High-frequency methylation observed in CDH1 (95%), p16 (20%), p14 (15%), DAPK1 (15%), and MGMT (15%).
- Promoter hypermethylation correlated with reduced protein production for CDH1, p16, RB1, and p14.
- Analysis revealed alterations in the RB1/p16 or p53 pathway in 70% of SCCs.
Conclusions:
- Promoter hypermethylation of cancer-related genes, especially CDH1, is a frequent event in SCCs.
- Dysregulation of the RB1/p16 and/or p53 pathways, via genetic or epigenetic mechanisms, contributes to SCC carcinogenesis.
- Epigenetic abnormalities of p53 itself were not implicated in this study's SCC cohort.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...

